LOGO.jpg
ROSEN, LEADING AND LONGSTANDING INVESTOR COUNSEL, Encourages PureCycle Technologies, Inc. Investors with Losses to Secure Counsel Before Important Deadline – PCT
May 15, 2021 16:15 ET | The Rosen Law Firm PA
NEW YORK, May 15, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of: (i) purchasers of the securities of...
LOGO.jpg
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Canoo Inc. f/k/a Hennessy Capital Acquisition Corp. IV Investors with Losses to Secure Counsel Before Important June 1 Deadline in Securities Class Action – GOEV
May 15, 2021 15:50 ET | The Rosen Law Firm PA
NEW YORK, May 15, 2021 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Canoo Inc. f/k/a Hennessy Capital Acquisition Corp. IV...
download.jpg
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Alerts Peloton Interactive (PTON) Investors to Securities Class Action, Investors with Losses Should Contact Us Now
May 15, 2021 15:32 ET | Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, May 15, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Peloton Interactive, Inc. (NASDAQ: PTON) investors with significant losses to submit your losses now. Class Period: Sept. 11,...
download.jpg
CCXI INVESTORS ACT NOW: Contact HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, to Recover Losses Due to Alleged Securities Fraud
May 15, 2021 15:25 ET | Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, May 15, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges ChemoCentryx, Inc. (NASDAQ: CCXI) investors with significant losses to submit your losses now. A securities fraud class action is...
download.jpg
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Advises Aterian (ATER) Investors to Contact the Firm Now to Recover Losses Due to Alleged Securities Fraud
May 15, 2021 15:19 ET | Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, May 15, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Aterian, Inc. (NASDAQ: ATER) f/k/a Mohawk Group Holdings (MWK) investors with significant losses to submit your losses now. A...
KTMC-Logo_RGB.jpg
Lead Plaintiff Deadline Approaching: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Securities Fraud Class Action Lawsuit Filed Against FibroGen, Inc. - Expanded Class Period
May 15, 2021 15:18 ET | Kessler Topaz Meltzer & Check LLP
RADNOR, Pa., May 15, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that securities fraud class action lawsuits have been filed in the United States...
download.jpg
SKLZ INVESTOR ALERT: Contact HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, to Recover Losses Due to Alleged Securities Fraud
May 15, 2021 14:50 ET | Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, May 15, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Skillz Inc. (NYSE: SKLZ) investors with significant losses to submit your losses now. A securities fraud class action is pending...
Miss Tram Beauty & Academy
Expert in natural makeup application continues to bring the best in natural beauty services to the Ho Chi Minh City
May 15, 2021 13:29 ET | Miss Tram Beauty & Academy
Ho Chi Minh, Vietnam, May 15, 2021 (GLOBE NEWSWIRE) -- Paris, Milan, and New York may be the places thought of when looking for the best in makeup services, but in the heart of Ho Chi Minh City, a...
KTMC-Logo_RGB.jpg
Deadline Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against Canoo Inc.
May 15, 2021 13:14 ET | Kessler Topaz Meltzer & Check LLP
RADNOR, Pa., May 15, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States...
Esperion Logo (primary).png
Simulation Model based on Pooled Phase 3 Data Demonstrating NEXLETOL® (bempedoic acid) Tablet’s Potential to Lower Absolute Cardiovascular Event Risk Presented at ACC.21
May 15, 2021 12:00 ET | Esperion Therapeutics, Inc.
- Patients with atherosclerotic cardiovascular disease (ASCVD) on maximally tolerated statins and treated with NEXLETOL predicted to experience a 3.3% further absolute reduction in 10-year...